Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.11. | SMOLTEK NANOTECH HOLDING AB: Smoltek publishes an interview with the company's CEO Håkan Persson | 1 | Cision News | ||
11.11. | SMOLTEK NANOTECH HOLDING AB: Smoltek Hydrogen participates in the Scandinavian delegation for meetings with the German hydrogen industry | 1 | Cision News | ||
07.11. | SMOLTEK NANOTECH HOLDING AB: Smoltek Hydrogen receives an order from a leading automotive manufacturer for electrodes used in fuel cells | 1 | Cision News | ||
05.11. | SMOLTEK NANOTECH HOLDING AB: Smoltek's groundbreaking technology for green hydrogen earns expert recognition | 1 | Cision News | ||
SMOLTEK NANOTECH Aktie jetzt für 0€ handeln | |||||
15.10. | SMOLTEK NANOTECH HOLDING AB: Smoltek Hydrogen has received an order for a preliminary study of electrochemical devices | 3 | Cision News | ||
11.10. | SMOLTEK NANOTECH HOLDING AB: Smoltek increases development speed with new zapping method | 1 | Cision News | ||
09.10. | SMOLTEK NANOTECH HOLDING AB: Smoltek strengthens its IP portfolio with a new patent in hydrogen technology - which increases the potential for cost-effective PEM electrolysis | 1 | Cision News | ||
26.09. | SMOLTEK NANOTECH HOLDING AB: Smoltek develops a new dielectric stack for the CNF-MIM capacitor technology boosting capacitance density by 230% | 3 | Cision News | ||
24.09. | SMOLTEK NANOTECH HOLDING AB: Smoltek and SparkNano present a joint whitepaper and hold a webinar about the collaboration | 1 | Cision News | ||
20.09. | SMOLTEK NANOTECH HOLDING AB: Warrants of series TO 8 were subscribed to approximately 0.02 percent and Smoltek receives approximately SEK 2 thousand | 1 | Cision News | ||
19.09. | SMOLTEK NANOTECH HOLDING AB: Smoltek is entitled to reduced employer contributions within R&D after reconsideration | 2 | Cision News | ||
10.09. | Spotlight Stock Market: Market Notice 178/24- Last day of trading in Smoltek Nanotech Holding AB's subscription option SMOL TO 8 | 2 | Cision News | ||
03.09. | SMOLTEK NANOTECH HOLDING AB: Smoltek achieves major hydrogen business breakthrough with A4-sized carbon nanofiber growth | 3 | Cision News | ||
10.07. | Recalculation of warrants of series TO 8 in Smoltek Nanotech Holding AB | 1 | Cision News | ||
05.07. | Spotlight Stock Market: Market Notice 143/24 - Last day of trading in Smoltek Nanotech Holding AB's BTA | 1 | Cision News | ||
05.07. | SMOLTEK NANOTECH HOLDING AB: Smoltek announces the last day of trading in BTA | 1 | Cision News | ||
02.07. | SMOLTEK NANOTECH HOLDING AB: Smoltek has been granted a new patent that improves the capacitance density of the company's CNF-MIM capacitors | 1 | Cision News | ||
27.06. | SMOLTEK NANOTECH HOLDING AB: The board of Smoltek has decided on a directed issue of shares to the underwriters in the completed rights issue | 1 | Cision News | ||
19.06. | Spotlight Stock Market: Market Notice 128/24 Information regarding Smoltek Nanotech Holding AB's subscribed share | 1 | Cision News | ||
19.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek has the technology for next-generation capacitors and is seeking financially strong partners to industrialize it | 1 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 46,550 | -1,06 % | Formycon: Zulassung zum Greifen nah - Druck auf Bayer wächst | Der deutsche Biosimilar-Entwickler Formycon hat eine wichtige Hürde auf dem Weg zur EU-Zulassung für den Eylea-Biosimilar-Kandidaten FYB203 genommen. Das Unternehmen kann die Empfehlung des Ausschusses... ► Artikel lesen | |
GAUZY | 7,480 | 0,00 % | CEO interview: Eyal Peso, Gauzy | ||
ONTO INNOVATION | 154,00 | 0,00 % | Finanzvorstand von Onto Innovation verkauft Aktien im Wert von 176.451 US-Dollar | ||
KOPIN | 0,950 | +4,86 % | Kopin Corp Q3 Loss Increases, But Beats Estimates | WASHINGTON (dpa-AFX) - Kopin Corp (KOPN) reported Loss for its third quarter that increased from last year but beat the Street estimates.The company's earnings came in at -$3.46 million, or... ► Artikel lesen | |
NVE | 72,50 | +0,69 % | Dividendenbekanntmachungen (04.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIANCEBERNSTEIN HOLDING LP US01881G1067 0,77 USD 0,7107 EUR AMCON DISTRIBUTING COMPANY US02341Q2057 0,18 USD 0,1661 EUR AMERIPRISE... ► Artikel lesen | |
DOTZ NANO | 0,051 | +4,12 % | DOTZ NANO LIMITED: Change of Director's Interest Notice - G Kelly | ||
FENDX TECHNOLOGIES | 0,115 | +1,32 % | FendX Technologies Inc.: FendX Announces Granting of United States Patent to Protect REPELWRAP Film | Oakville, Ontario--(Newsfile Corp. - November 14, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection... ► Artikel lesen | |
ACACIA RESEARCH | 4,080 | 0,00 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,442 | +0,45 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
LEHNER INVESTMENTS | 0,015 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
NANOFOCUS | 1,310 | 0,00 % | NanoFocus passt Prognose für 2024 an | Die NanoFocus AG hat heute beschlossen, die Prognose für das laufende Jahr anzupassen. Aufgrund von gegenwärtig absehbar deutlich niedrigeren Umsätzen in den Bereichen Semiconductor Asia und Standard/Labor... ► Artikel lesen | |
RIBER | 2,500 | -0,79 % | RIBER: Solid Business Growth at End-September 2024 | SOLID BUSINESS GROWTH AT END-SEPTEMBER 2024 Revenues up +14% to €18.5mOrder book strengthened to €38.3m (+14%) Bezons, October 30, 2024 - 8:00am - RIBER, the global leader for molecular beam epitaxy... ► Artikel lesen | |
NANOVIRICIDES | 1,270 | 0,00 % | NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID | SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September... ► Artikel lesen | |
GOMSPACE | 0,325 | 0,00 % | GOMSPACE A/S: ESA and GomSpace sign 8.4 MSEK contract change notice for the GOMX-5 project | ||
REGION GROUP | 1,286 | +0,44 % | REGION GROUP: Initial Director's Interest Notice |